Lung cancer

被引：8
作者：
Crino, Lucio [1 ]
Foglietta, Jennifer [1 ]
Hamzaj, Alketa [1 ]
机构：
[1] Perugia Hosp, Dept Med Oncol, Perugia, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2007年 / 2卷 / 05期
关键词：
D O I：
10.1097/01.JTO.0000268637.10332.e3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S24 / S26
页数：3
相关论文
共 32 条
[1]  
ALBERTI W, 1995, BRIT MED J, V311, P899
[2]  
[Anonymous], CHEST
[3]   Pharmacogenomics: A reality or still a promise? [J].
Bepler, Gerold .
LUNG CANCER, 2006, 54 :S3-S7
[4]   A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) [J].
Blumenschein, G ;
Ludwig, C ;
Thomas, G ;
Tan, E ;
Fanucchi, M ;
Santoro, A ;
Crawford, J ;
Breton, J ;
O'Brien, M ;
Khuri, F .
LUNG CANCER, 2005, 49 :S30-S30
[5]  
BLUMENSCHEIN GR, 2005, J CLIN ONCOL, V23, P7001
[6]  
Bunn PA, 1998, CLIN CANCER RES, V4, P1087
[7]   Phase II trial of pemetrexed disodium (ALIMTA®, LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer [J].
Clarke, SJ ;
Abratt, R ;
Goedhals, L ;
Boyer, MJ ;
Millward, MJ ;
Ackland, SP .
ANNALS OF ONCOLOGY, 2002, 13 (05) :737-741
[8]  
Haus B M, 2001, Curr Opin Pulm Med, V7, P220, DOI 10.1097/00063198-200107000-00010
[9]   ZD6474 plus docetaxel in patients with previously treated NSCLC: Results of a randomized, placebo-controlled Phase II trial [J].
Herbst, R ;
Johnson, B ;
Rowbottom, J ;
Fidias, P ;
Lu, C ;
Prager, D ;
Roubec, J ;
Csada, E ;
Dimery, I ;
Heymach, J .
LUNG CANCER, 2005, 49 :S35-S36
[10]   COUNTING THE COSTS OF CHEMOTHERAPY IN A NATIONAL-CANCER-INSTITUTE-OF-CANADA RANDOMIZED TRIAL IN NONSMALL-CELL LUNG-CANCER [J].
JAAKKIMAINEN, L ;
GOODWIN, PJ ;
PATER, J ;
WARDE, P ;
MURRAY, N ;
RAPP, E .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) :1301-1309
1234